Lu Gan

Lu Gan

Company: Scholar Rock

Job title: VP, Head of Medical Research/Oncology Franchise


SRK-181, A Latent TGF-β Inhibitor: Safety & Efficacy Results From the Dose Escalation Portion of a Phase I Trial (DRAGON Trial) in Patients with Advanced Solid Tumors 4:20 pm

Exploring the SRK-181 mechanism of action and study design Navigating dose escalation and safety data to determine how high the dose and what the safety profile of the therapeutic looks likeRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.